Skip to main content
. 2017 Sep 27;2017(9):CD011469. doi: 10.1002/14651858.CD011469.pub2
Trial All hypoglycaemic events Severe/serious hypoglycaemia Nocturnal hypoglycaemia Severe/serious
 adverse events
Beverly 2013 NI NI NI NI
Davies 2008 NI NI NI NI
Dennick 2015 NI NI NI ND
D'Eramo Melkus 2010 NI NI NI NI
Fisher 2011 IO (< 70 mg/dL or 3.9 mmol/L, based on downloaded meter data) NI NI IO
Fisher 2013 NI NI NI NI
Gabbay 2013 NI NI NI NI
Glasgow 2005 NI NI NI NI
Grillo 2016 NI NI NI NI
Hermanns 2012 NI NI NI NI
Hermanns 2015 NI NI NI NI
Lamers 2011 SO NI NI ND
Lerman 2009 NI NI NI NI
Liu 2015 NI NI NI NI
Pibernik‐Okanovic 2015 NI NI NI ND
Quinn 2011 SO (through quarterly telephone calls to patients) NI NI SO
Rosenbek 2011 NI NI NI NI
Shibayama 2007 NI NI NI NI
Simmons 2015 NI NI NI NI
Skelly 2009 NI NI NI NI
Spencer 2013 NI NI NI NI
Sperl‐Hillen 2013 NI NI NI NI
Sturt 2008 NI NI NI NI
Taylor 2006 NI NI NI ND
Trief 2016 NI NI NI NI
Van der Wulp 2012 NI NI NI NI
Van Dijk‐de Vries 2015 NI NI NI NI
Weinger 2011 ND SO ND ND
Welch 2015 SO (hypoglycaemia was defined in the Diabetes Self‐Care Profile as any "low blood sugars or sweating, nausea, heart pounding, trembling,cold and clammy skin, difficulty concentrating, and irritability" over the past month) SO NI NI
Whittemore 2004 NI NI NI NI
aIn addition to definition of endpoint measurement, description of who measured the outcome (AO: adjudicated outcome measurement; IO: investigator‐assessed outcome measurement;SO: self‐reported outcome measurement)
ND: not defined; NI: not investigated